Analysts warm to MarshMac amid Putnam sale

Marsh & McLennan, the US insurer preparing to sell its fund management unit Putnam Investments, has earned a buy rating from a second major investment bank, which thinks the shares will rise once the funds business is sold and improvements are made to a brokerage division.

The upgrade is the second from a major bank since the stock fell below $25 in August. Marsh's share price has suffered since October 2004 when the company was named by Eliot Spitzer in a bid rigging lawsuit. Chief executive Jeffrey Greenberg resigned and was replaced by Michael Cherkasky.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump